Fragment-based drug design coupled with AI/ML prediction enables identification of novel PARP-1 inhibitors against triple-negative breast cancer

Journal of Molecular Graphics and Modelling 2026

View at publisher

Authors: Aayushi Bhatnagar, Virendra Nath, Vipin Kumar

DOI: 10.1016/j.jmgm.2026.109327

Cited by: 0

References: 38

Fields of Study & Subjects

Computational Drug Discovery Methods PARP inhibition in cancer therapy Synthesis and Characterization of Heterocyclic Compounds

References 38